These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [A double blind study of the new hypolipidemic agent pirozadil (722-D) using patients with ischemic heart disease (author's transl)]. Cadierno Carpintero M; Emeterio Reig E; Soler Masana JM Med Clin (Barc); 1982 May; 78(9):386-9. PubMed ID: 7047927 [No Abstract] [Full Text] [Related]
5. [Comparative study of the action of hypolipemic and antioxidant drugs in ischemic heart disease]. Kalmykova VI; Nikitina EK; Bezzubov AA Sov Med; 1986; (3):81-4. PubMed ID: 3520867 [No Abstract] [Full Text] [Related]
6. [Clinical trial of a new drug for the treatment of atherosclerosis: pirozadil (722-D) (author's transl)]. Marín Plaza R; Díaz González JM; Varela de Seijas JR Med Clin (Barc); 1982 May; 78(10):427-32. PubMed ID: 7047924 [No Abstract] [Full Text] [Related]
7. [Milestone in the treatment of diabetic dyslipidemia: the DAIS Study]. Forster T Orv Hetil; 2001 Jul; 142(29):1588-9. PubMed ID: 11494751 [No Abstract] [Full Text] [Related]
9. [Vitamin E treatment of patients with coronary disease (Cambridge Heart Antioxidant Study--CHAOS)]. Mörike EM Dtsch Med Wochenschr; 1996 May; 121(21):A9. PubMed ID: 8646973 [No Abstract] [Full Text] [Related]
10. [Assessment of hypolipemic action of the preparation olbetam in people with primary hypercholesterolemia]. Miturzyńska-Stryjecka H; Widomska-Czekajska T; Bielak G; Grossmann G Wiad Lek; 1994 Aug; 47(15-16):566-9. PubMed ID: 7716950 [No Abstract] [Full Text] [Related]
11. Trials and tribulations. Packard CJ Int J Clin Pract Suppl; 2002 Oct; (132):3-10. PubMed ID: 12425357 [No Abstract] [Full Text] [Related]
12. Lipid-lowering effects of colesevelam HCl in combination with ezetimibe. Bays H; Rhyne J; Abby S; Lai YL; Jones M Curr Med Res Opin; 2006 Nov; 22(11):2191-200. PubMed ID: 17076980 [TBL] [Abstract][Full Text] [Related]
13. Treadmill testing and selection of hypercholesterolemic patients for treatment. Vine DL Kans Med; 1989 Nov; 90(11):323-4. PubMed ID: 2687549 [No Abstract] [Full Text] [Related]
14. [Statins in practice of the vascular surgeon and cardiologist]. Pokrovskiĭ AV; Suntsov DS Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952 [TBL] [Abstract][Full Text] [Related]
15. Statins and strokes--reducing the risk. Jackson G Int J Clin Pract; 1999; 53(3):159. PubMed ID: 10665124 [No Abstract] [Full Text] [Related]
16. Effectiveness of short-term sulodexide treatment on peripheral vascular disease clinical manifestations. Caramelli L; Mirchioni R; Carini A Riv Eur Sci Med Farmacol; 1988 Feb; 10(1):55-8. PubMed ID: 3079198 [No Abstract] [Full Text] [Related]
17. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Briel M; Studer M; Glass TR; Bucher HC Am J Med; 2004 Oct; 117(8):596-606. PubMed ID: 15465509 [TBL] [Abstract][Full Text] [Related]
19. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)]. Fourrier A; Mouton Y Lille Med; 1974 Apr; 19(4 Suppl 11):532-7. PubMed ID: 4612283 [No Abstract] [Full Text] [Related]